Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › BTLA agonist antibodies and uses thereof

BTLA agonist antibodies and uses thereof

US Patent 10604573 · Granted Mar 31, 2020

Estimated economic value: $461,805,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and methods targeting interleukin-342024
IgG bispecific antibodies and processes for preparation2024
Human interleukin-4 receptor alpha antibodies2024
Antibodies to IL-342023
Parathyroid hormone-anti-RANKL antibody fusion compounds2022
BTLA agonist antibodies and uses thereof2022
BTLA agonist antibodies and uses thereof2022
BTLA agonist antibodies and uses thereof2022
Growth differentiation factor 15 agonist compounds and methods of using the same2021
Anti-RANKL antibodies and uses thereof2021
IgG bispecific antibodies and processes for preparation2020
Anti-Dkk-1-anti-RANKL bispecific antibody compounds2020